Larimar Therapeutics, Inc.
NASDAQ:LRMR
7.36 (USD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 26.749 | 26.825 | 70.097 | 68.148 | 1.009 | 49.331 | 40.777 | 32.352 | 35.595 | 58.103 |
| Short Term Investments
| 60.041 | 91.603 | 0 | 24.49 | 43.05 | 68.735 | 61.275 | 96.842 | 149.484 | 57.359 |
| Cash and Short Term Investments
| 86.79 | 118.428 | 70.097 | 92.638 | 1.009 | 118.066 | 102.052 | 129.194 | 185.079 | 115.462 |
| Net Receivables
| 0 | 0 | 0.208 | 0.032 | 0.158 | 1.536 | 0.946 | 0.347 | 1.323 | 0 |
| Inventory
| 0 | 0 | -0.208 | -0.032 | 3.164 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.385 | 2.311 | 2.107 | 5.314 | 0.419 | 1.728 | 1.927 | 1.358 | 1.708 | 1.736 |
| Total Current Assets
| 90.175 | 120.739 | 72.204 | 97.952 | 4.75 | 121.33 | 104.925 | 130.899 | 188.11 | 117.198 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 3.762 | 3.689 | 4.455 | 4.976 | 0.361 | 0.375 | 0.528 | 0.661 | 0.902 | 0.079 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.339 | 1.339 | 1.339 | 1.339 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.659 | 0.638 | 0.669 | 0.419 | 0.09 | 0.057 | 0.057 | 0.061 | 0.094 | 0.242 |
| Total Non-Current Assets
| 5.76 | 5.666 | 6.463 | 6.734 | 0.451 | 0.432 | 0.585 | 0.722 | 0.996 | 0.321 |
| Total Assets
| 95.935 | 126.405 | 78.667 | 104.686 | 5.201 | 121.762 | 105.51 | 131.621 | 189.106 | 117.519 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 1.283 | 1.686 | 1.66 | 2.634 | 3.539 | 3.59 | 3.02 | 2.572 | 7.495 | 2.348 |
| Short Term Debt
| 0.837 | 0.611 | 0.594 | 0.515 | 0.097 | 5.455 | 0 | 3.589 | 2.936 | 1.381 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | -5.455 | 0 | -2.572 | -2.936 | 0 |
| Other Current Liabilities
| 7.386 | 8.408 | 6.592 | 5.843 | 2.259 | 9.716 | 4.273 | 6.305 | 9.048 | 3.172 |
| Total Current Liabilities
| 9.506 | 10.705 | 8.846 | 8.992 | 5.895 | 13.306 | 7.293 | 9.894 | 16.543 | 6.901 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 4.709 | 4.797 | 5.408 | 6.002 | 14.92 | 15.185 | 20 | 0 | 3.453 | 6.177 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Total Non-Current Liabilities
| 4.709 | 4.797 | 5.408 | 6.002 | 14.92 | 15.185 | 20 | 0 | 3.453 | 6.177 |
| Total Liabilities
| 14.215 | 15.502 | 14.254 | 14.994 | 5.895 | 28.491 | 27.293 | 9.894 | 19.996 | 13.078 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117.519 |
| Common Stock
| 0.043 | 0.043 | 0.018 | 0.015 | 0.006 | 0.037 | 0.027 | 0.027 | 0.027 | 0.023 |
| Retained Earnings
| -188.554 | -151.605 | -116.25 | -65.614 | -23.132 | -350.945 | -289.577 | -237.549 | -179.671 | -105.385 |
| Accumulated Other Comprehensive Income/Loss
| 0.081 | -0.031 | -0 | 0.001 | 0.035 | -0.033 | -0.058 | -0.08 | -0.207 | -0.035 |
| Other Total Stockholders Equity
| 270.15 | 262.496 | 180.645 | 155.29 | 22.397 | 444.212 | 367.825 | 359.329 | 348.961 | 92.319 |
| Total Shareholders Equity
| 81.72 | 110.903 | 64.413 | 89.692 | -0.694 | 93.271 | 78.217 | 121.727 | 169.11 | 104.441 |
| Total Equity
| 81.72 | 110.903 | 64.413 | 89.692 | -0.694 | 93.271 | 78.217 | 121.727 | 169.11 | 104.441 |
| Total Liabilities & Shareholders Equity
| 95.935 | 126.405 | 78.667 | 104.686 | 5.201 | 121.762 | 105.51 | 131.621 | 189.106 | 117.519 |